Jan 04 by Andy Gillin

Report: FDA Allowed Major Oversight Loopholes for DePuy Faulty Hip Implants

Late last year, the Food and Drug Administration announced that it would recall hip implants manufactured by DePuy Orthopedics, a division of pharmaceutical giant Johnson & Johnson due to an abnormally high number of hip implant failures, which some predicted could easily surpass 12,000. At the time, DePuy critics were quick to note that the ASR hip implant models hit the market without FDA oversight thanks to a loophole that greenlights a product if it is similar to a device already approved by the agency. Last month, the New York Times published a scathing report about DePuy and the FDA, showing just how easy it was for the J&J subsidiary to put a dangerous product on the market.

Read More